RLAY: Relay Therapeutics, Inc. Common Stock Company Profile & Statistics

About

Relay Therapeutics Inc. is a clinical-stage precision medicines company. It focuses on enhancing small molecule therapeutic discovery in targeted oncology. The company's product pipeline consist RLY-1971, RLY-4008 and RLY-PI3K1047 which are in clinical stage. Relay Therapeutics Inc. is based in Cambridge, Massachusetts.

Info & Links

CEO

Sanjiv K. Patel

Headquarters

399 BINNEY STREET, 2ND FLOOR
CAMBRIDGE, MA 02139, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

323

Relay Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

577.39M

Enterprise Value

425.03M

Enterprise Value/EBITDA(ttm)

-1.10

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

0.81

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

25.00%

Operating Margin(ttm)

Profit Margin(ttm)

-203.33%

Return on Equity(ttm)

-45.75%

Return on Invested Capital(ttm)

-44.71%

Return on Assets(ttm)

-40.75%

Income Statement

Revenue(ttm)

10.01M

Revenue Per Share(ttm)

0.06

Gross Profit(ttm)

10.01M

EBITDA(ttm)³

-387.98M

Net Income Available to Common(ttm)

-345.20M

Diluted EPS(ttm)

-2.61

Share Statistics

Beta (5Y Monthly)

1.61

52-Week Change

-65.91%

S&P 500 52-Week Change

12.74%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

167.38M

Dividend Yield

0.00%

Float⁴

160.15M

% Held by Insiders

4.32%

% Held by Institutions

96.98%

Balance Sheet

Total Cash(mrq)

839.61M

Total Cash Per Share(mrq)

5.02

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

15.95%

Quick Ratio(mrq)

18.42%

Book Value Per Share(mrq)

4.64

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.74

Free Cash Flow(ytd)

-251.13M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

RLAY

Relay Therapeutics, Inc. Common Stock

Relay Therapeutics, Inc. Common Stock Profile